The incorporation of [1-14C]-linoleic acid and [1-14C]-arachidonic acid into the lipids of ovine placental homogenate was studied. Both fatty acids were incorporated mainly into the phospholipid fraction with much lower levels being found in the diacylglycerols and triacylglycerols, particularly when the substrate was [1–14C]-arachidonic acid. Within the phospholipid fraction, both substrates were incorporated largely into phosphatidic acid although significant levels of incorporation were found in the phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol fractions. The incorporation of [1-14C]-arachidonic acid into phosphatidylcholine was lower and into phosphatidylethanolamine and phosphatidylinositol was higher than those levels found when the substrate used was [1–14C]-linoleic acid. While some of the trienoic and tetraenoic, but not pentaenoic, desaturation products of [1-14C]-linoleic acid were detected in phosphatidylcholine and phosphatidylethanolamine, the highest levels of incorporation of these metabolites were into phosphatidic acid. Similarly, the pentaenoic products of [1-14C]-arachidonic acid were found mainly in phosphatidic acid although significantly higher levels were observed in phosphatidylcholine, phosphatidylethanolamine and phosphatidylinositol. The results suggest that in ovine placental tissue polyunsaturated fatty acids, whether supplied pre-formed or made available by desaturation and elongation processes, could potentially be incorporated into phospholipids by the de novo route via phosphatidic acid.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.